Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Credit Suisse price target raised to CHF 12.50 from CHF 12 at Barclays » 14:48
07/30/21
07/30
14:48
07/30/21
14:48
CS

Credit Suisse

$9.99 /

+ (+0.00%)

Barclays analyst Amit…

Barclays analyst Amit Goel raised the firm's price target on Credit Suisse to CHF 12.50 from CHF 12 and keeps an Overweight rating on the shares.

ShowHide Related Items >><<
CS Credit Suisse
$9.99 /

+ (+0.00%)

CS Credit Suisse
$9.99 /

+ (+0.00%)

07/30/21 JPMorgan
Credit Suisse price target lowered to CHF 11.60 from CHF 11.70 at JPMorgan
07/30/21 RBC Capital
Credit Suisse price target lowered to CHF 10.50 from CHF 11 at RBC Capital
07/19/21 Barclays
Credit Suisse price target lowered to CHF 12 from CHF 12.50 at Barclays
07/15/21 Jefferies
Credit Suisse initiated with a Hold at Jefferies
CS Credit Suisse
$9.99 /

+ (+0.00%)

CS Credit Suisse
$9.99 /

+ (+0.00%)

CS Credit Suisse
$9.99 /

+ (+0.00%)

CS Credit Suisse
$9.99 /

+ (+0.00%)

Recommendations
Credit Suisse price target lowered to CHF 11.60 from CHF 11.70 at JPMorgan » 14:42
07/30/21
07/30
14:42
07/30/21
14:42
CS

Credit Suisse

$10.00 /

+0.005 (+0.05%)

JPMorgan analyst Kian…

JPMorgan analyst Kian Abouhossein lowered the firm's price target on Credit Suisse to CHF 11.60 from CHF 11.70 and keeps a Neutral rating on the shares.

ShowHide Related Items >><<
CS Credit Suisse
$10.00 /

+0.005 (+0.05%)

CS Credit Suisse
$10.00 /

+0.005 (+0.05%)

07/30/21 RBC Capital
Credit Suisse price target lowered to CHF 10.50 from CHF 11 at RBC Capital
07/19/21 Barclays
Credit Suisse price target lowered to CHF 12 from CHF 12.50 at Barclays
07/15/21 Jefferies
Credit Suisse initiated with a Hold at Jefferies
07/13/21 Deutsche Bank
Credit Suisse price target lowered to CHF 11 from CHF 12 at Deutsche Bank
CS Credit Suisse
$10.00 /

+0.005 (+0.05%)

CS Credit Suisse
$10.00 /

+0.005 (+0.05%)

CS Credit Suisse
$10.00 /

+0.005 (+0.05%)

CS Credit Suisse
$10.00 /

+0.005 (+0.05%)

Recommendations
Credit Suisse price target lowered to CHF 10.50 from CHF 11 at RBC Capital » 14:27
07/30/21
07/30
14:27
07/30/21
14:27
CS

Credit Suisse

$10.00 /

+0.005 (+0.05%)

RBC Capital analyst Anke…

RBC Capital analyst Anke Reingen lowered the firm's price target on Credit Suisse to CHF 10.50 from CHF 11 and keeps a Sector Perform rating on the shares.

ShowHide Related Items >><<
CS Credit Suisse
$10.00 /

+0.005 (+0.05%)

CS Credit Suisse
$10.00 /

+0.005 (+0.05%)

07/19/21 Barclays
Credit Suisse price target lowered to CHF 12 from CHF 12.50 at Barclays
07/15/21 Jefferies
Credit Suisse initiated with a Hold at Jefferies
07/13/21 Deutsche Bank
Credit Suisse price target lowered to CHF 11 from CHF 12 at Deutsche Bank
07/12/21 Morgan Stanley
Credit Suisse price target lowered to CHF 10 from CHF 11 at Morgan Stanley
CS Credit Suisse
$10.00 /

+0.005 (+0.05%)

CS Credit Suisse
$10.00 /

+0.005 (+0.05%)

CS Credit Suisse
$10.00 /

+0.005 (+0.05%)

CS Credit Suisse
$10.00 /

+0.005 (+0.05%)

Thursday
Hot Stocks
Credit Suisse publishes report on independent investigation into Archegos » 06:33
07/29/21
07/29
06:33
07/29/21
06:33
CS

Credit Suisse

$10.28 /

+0.06 (+0.59%)

Credit Suisse Group…

Credit Suisse Group published the report based on the independent external investigation into Archegos Capital Management, which was commissioned by the Board of Directors and supervised by a special committee of the Board. Over the past months, at the direction of the Board of Directors, Paul, Weiss, Rifkind, Wharton & Garrison LLP and its expert advisors conducted a comprehensive review of Credit Suisse's relationship with Archegos following the US hedge fund's default on March 25, 2021. The review consisted of more than 80 interviews with current and former Credit Suisse employees as well as the collection of more than 10 million documents and other data. Among some of the key conclusions, the investigation found a failure to effectively manage risk in the Investment Bank's Prime Services business by both the first and second lines of defense as well as a lack of risk escalation. In the same business, it also found a failure to control limit excesses across both lines of defense as a result of an insufficient discharge of supervisory responsibilities in the Investment Bank and in Risk, as well as a lack of prioritization of risk mitigation and enhancement measures. However, the investigation also found that this was not a situation where the business and risk personnel engaged in fraudulent or illegal conduct or acted with ill intent. Nor was it one where the architecture of risk controls and processes was lacking, or the existing risk systems failed to operate sufficiently to identify critical risks and related concerns. Under the leadership of the Tactical Crisis Committee of the Board - which consists of the Chairman of the Board, the Chair of the Audit Committee, the Chair of the Risk Committee, and the Chair of the Conduct and Financial Crime Control Committee - and in close collaboration with the Group Chief Executive Officer and selected members of senior management, including the ad interim Chief Risk Officer, the Chief Financial Officer, the General Counsel, the ad interim Chief Compliance Officer, the new CEO of the Investment Bank Division, and the Head Internal Audit, the bank has already implemented a series of key recommendations. These implementation steps have included several changes in senior leadership at the Investment Bank, including in the Prime Services business, and initiating the recruitment of additional resources for the Risk function. Furthermore, over the past months, a review of all large group-wide exposures and a revision of limit excess controls and escalation requirements has been conducted. A number of risk-governance bodies have been reviewed and upgraded, and a reduced risk appetite across the organization has been implemented together with additional approval requirements for all material transactions. Through this exercise, the bank has significantly reduced the risk-weighted assets and leverage exposure in the Prime Services business while increasing margin requirements, and all hedge fund clients have been moved to dynamic margining. In addition, the bank has commissioned a review of double-hatted roles. A key aspect of the overall review considered individual accountability, with subsequent actions taken on 23 individuals. These actions include termination of employment and severe monetary penalties totaling approximately USD 70 mn in the aggregate via compensation adjustment tools encompassing up to 100% malus. The bank will provide a full accounting of the implicit and explicit compensation consequences for the Archegos incident in the Compensation Report after the close of the year. Finally, earlier this week, the bank announced the appointment of David Wildermuth as the new CRO, joining from Goldman Sachs and bringing a wealth of relevant risk management experience with him. He will commence his new role in early 2022. Until then, and as originally planned and announced in early April 2021, Joachim Oechslin, will continue as ad interim CRO. Joachim Oechslin and Richard Meddings, the ad interim Chair of the Risk Committee, have both been instrumental in leading and implementing the above described risk management improvement steps.

ShowHide Related Items >><<
CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

07/19/21 Barclays
Credit Suisse price target lowered to CHF 12 from CHF 12.50 at Barclays
07/15/21 Jefferies
Credit Suisse initiated with a Hold at Jefferies
07/13/21 Deutsche Bank
Credit Suisse price target lowered to CHF 11 from CHF 12 at Deutsche Bank
07/12/21 Morgan Stanley
Credit Suisse price target lowered to CHF 10 from CHF 11 at Morgan Stanley
CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

Hot Stocks
Credit Suisse: CSAM focus is returning cash to investors, maximizing recoveries » 06:30
07/29/21
07/29
06:30
07/29/21
06:30
CS

Credit Suisse

$10.28 /

+0.06 (+0.59%)

The company said,…

The company said, "On the SCFF matter, returning cash to investors and maximizing recoveries remain CSAM's top priority. Taking into account the upcoming fourth distribution, planned for the first half of August, of approximately USD 0.4 bn, the total cash distribution to investors will stand at approximately USD 5.9 bn. Together with the cash distributed to date and cash remaining in the funds, the cash position is equivalent to approximately USD 6.6 bn, or 66%, of the funds' net asset value at the time of their suspension. With regard to the three 'focus' areas, where we expect recovery to be more complex and take more time, we are in advanced negotiations with certain debtors on restructuring to maximize recovery, and we have set up dedicated teams of more than 60 internal and external experts as part of our efforts to maximize and expedite asset recovery. In respect of our non-focus areas, we expect overall recovery of more than 90%. Finally, on insurance, we continue to work on filing insurance claims with the aid of Greensill Bank."

ShowHide Related Items >><<
CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

07/19/21 Barclays
Credit Suisse price target lowered to CHF 12 from CHF 12.50 at Barclays
07/15/21 Jefferies
Credit Suisse initiated with a Hold at Jefferies
07/13/21 Deutsche Bank
Credit Suisse price target lowered to CHF 11 from CHF 12 at Deutsche Bank
07/12/21 Morgan Stanley
Credit Suisse price target lowered to CHF 10 from CHF 11 at Morgan Stanley
CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

Hot Stocks
Credit Suisse reports outcome of independent investigation into Archegos matter » 06:26
07/29/21
07/29
06:26
07/29/21
06:26
CS

Credit Suisse

$10.28 /

+0.06 (+0.59%)

The company…

The company said,"The Board of Directors commissioned two externally led investigations into the Archegos and supply chain finance funds matters, both of which were supervised by a special committee. The investigation into the supply chain finance funds matter is still ongoing and is expected to be completed in 3Q21. Today we announced the outcome of the independent investigation into the Archegos matter and published the full externally-led report commissioned by the Board of Directors' special committee. A summary of the findings can be found in the separate media release published at 06.45 CEST on July 29, 2021. Select key findings from the independent investigation into Archegos include failure to: Effectively manage risk in our Prime Services business by both first and second lines of defense; Escalate risks and to control limit excesses across first and second lines of defense; Discharge supervisory responsibilities across first and second lines of defense rioritize risk mitigation and enhancement measures. However, the investigation also found that, this was not a situation where the business and risk personnel engaged in fraudulent or illegal conduct or acted with ill intent. Nor was it one where the architecture of risk controls and processes was lacking, or the existing risk systems failed to operate sufficiently to identify critical risks and related concerns. Of the selected key recommendations presented by the independent authors of the report, we have completed or are in progress of completing the following: Change leadership in the Investment Bank, including Prime Services, and Risk; Invest in additional resources to improve risk management; Clearly define roles, responsibilities and accountability; Strengthen existing processes to protect Credit Suisse from risk; Re-examine counterparty risk appetite and controls; Improve quality of risk information and access; Conduct a read-across and further improve risk culture. All of the remaining long and short positions in Archegos were exited in early June and Credit Suisse took appropriate HR-related actions, including terminations and monetary penalties. The financial impact of Archegos on Credit Suisse's pre-tax income was CHF 594 mn in 2Q21 and CHF 5.0 bn in 1H21. Moreover, Credit Suisse reserves its right to pursue claims against various third parties.

ShowHide Related Items >><<
CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

07/19/21 Barclays
Credit Suisse price target lowered to CHF 12 from CHF 12.50 at Barclays
07/15/21 Jefferies
Credit Suisse initiated with a Hold at Jefferies
07/13/21 Deutsche Bank
Credit Suisse price target lowered to CHF 11 from CHF 12 at Deutsche Bank
07/12/21 Morgan Stanley
Credit Suisse price target lowered to CHF 10 from CHF 11 at Morgan Stanley
CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

Hot Stocks
Credit Suisse expects more normal levels of market volumes in coming quarters » 06:22
07/29/21
07/29
06:22
07/29/21
06:22
CS

Credit Suisse

$10.28 /

+0.06 (+0.59%)

The company said,…

The company said, "Overall, we continue to expect more normal levels of market volumes in the coming quarters of 2021 compared to the elevated levels seen in 2020. Furthermore, for the course of the ongoing review of the Group's business strategy, we expect to continue to adopt a more conservative approach to risk. In Wealth Management, we expect recurring commissions and fees to continue to benefit from higher levels of AuM as well as increased levels of mandate penetration, together with broadly stable net interest income. For the Investment Bank, we would expect the third quarter to reflect the usual seasonal slowdown in market activity, as well as some further impact from the resizing of our Prime Services business. We have a strong M&A advisory pipeline up both sequentially and notably on a year on year basis and our pipelines across ECM and leveraged finance are also robust. The ongoing recovery in the global economy could allow us to continue to release part of our allowance for credit losses, which was built in the early months of the COVID-19 crisis last year, under the CECL accounting methodology. As we noted at the end of the first quarter, we would, though, expect the effective tax rate to remain significantly elevated for the remainder of the year. Following significant strengthening of our capital ratios in 2Q21, we continue to intend to operate with a CET1 ratio of at least 13% and a CET1 leverage ratio of at least 4%."

ShowHide Related Items >><<
CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

07/19/21 Barclays
Credit Suisse price target lowered to CHF 12 from CHF 12.50 at Barclays
07/15/21 Jefferies
Credit Suisse initiated with a Hold at Jefferies
07/13/21 Deutsche Bank
Credit Suisse price target lowered to CHF 11 from CHF 12 at Deutsche Bank
07/12/21 Morgan Stanley
Credit Suisse price target lowered to CHF 10 from CHF 11 at Morgan Stanley
CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

Earnings
Credit Suisse reports Q2 net revenue CHF 5.1B vs. CHF 6.19B last year » 06:20
07/29/21
07/29
06:20
07/29/21
06:20
CS

Credit Suisse

$10.28 /

+0.06 (+0.59%)

Reports Q2 adjusted…

Reports Q2 adjusted pre-tax income CHF 1.3B vs. CHF 1.48B last year. Reports Q2 CET1 ratio 13.7% vs. 12.5% last year. Thomas Gottstein, CEO of Credit Suisse Group AG, commented: ""Credit Suisse delivered resilient underlying second quarter results and strong capital ratios as we are benefitting from having taken decisive actions to address the challenges raised by the Archegos and Supply Chain Finance Funds matters. We take these two events very seriously and we are determined to learn all the right lessons. We have significantly reduced our RWA and leverage exposure and improved the risk profile of our Prime Services business in the Investment Bank, as well as strengthened the overall risk capabilities across the bank. Our underlying business performance remains solid with a record level of assets under management in our Wealth Management and Asset Management businesses, supporting strong growth in recurring commissions and fees. Together with our more conservative approach to risk and a less favorable trading environment compared to the second quarter of 2020, we delivered a resilient underlying performance in the Investment Bank. We continue to invest in people and technology across Wealth Management, notably in APAC, as well as Asset Management and the Investment Bank. Over the coming months, we will continue to develop our long-term vision for the bank that will serve as our compass for the years ahead. Our objectives are clear: whilst we aim to further strengthen our risk culture, we remain committed to serving all our private, corporate and institutional clients with best-in-class service and advice and to creating value for our shareholders."

ShowHide Related Items >><<
CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

07/19/21 Barclays
Credit Suisse price target lowered to CHF 12 from CHF 12.50 at Barclays
07/15/21 Jefferies
Credit Suisse initiated with a Hold at Jefferies
07/13/21 Deutsche Bank
Credit Suisse price target lowered to CHF 11 from CHF 12 at Deutsche Bank
07/12/21 Morgan Stanley
Credit Suisse price target lowered to CHF 10 from CHF 11 at Morgan Stanley
CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

Wednesday
On The Fly
Wall Street in Fives - Must Read Lists for Wednesday » 16:53
07/28/21
07/28
16:53
07/28/21
16:53
AAPL

Apple

$144.98 /

-1.8 (-1.23%)

, GOOG

Alphabet

$2,727.64 /

-4.57 (-0.17%)

, GOOGL

Alphabet Class A

$2,722.81 /

+84.175 (+3.19%)

, MSFT

Microsoft

$286.12 /

-0.77 (-0.27%)

, PFE

Pfizer

$43.45 /

+1.39 (+3.30%)

, SPX

S&P 500

/

+

, SPY

SPDR S&P 500 ETF Trust

$438.80 /

-0.1901 (-0.04%)

, TDOC

Teladoc

$152.12 /

+1.3 (+0.86%)

, MGM

MGM Resorts

$38.40 /

+0.37 (+0.97%)

, RMD

ResMed

$266.01 /

+1.61 (+0.61%)

, FLDM

Fluidigm

$7.10 /

+0.74 (+11.64%)

, CS

Credit Suisse

$10.28 /

+0.06 (+0.59%)

, TWTR

Twitter

$69.94 /

+1.62 (+2.37%)

, BAX

Baxter

$82.00 /

-0.13 (-0.16%)

, HRC

Hill-Rom

$132.69 /

+8.92 (+7.21%)

, GIW

GigInternational1

$9.82 /

-0.04 (-0.41%)

, ASXC

Asensus Surgical

$2.37 /

+0.22 (+10.23%)

, TEVA

Teva

$9.99 /

+1.075 (+12.06%)

, TLRY

Tilray

$16.00 /

+3.27 (+25.69%)

, HMLP

Hoegh LNG Partners

$6.30 /

-11.485 (-64.60%)

, CFG

Citizens Financial

$43.30 /

-1.025 (-2.31%)

, ISBC

Investors Bancorp

$14.43 /

+1.42 (+10.91%)

, CAKE

Cheesecake Factory

$47.76 /

-7.32 (-13.29%)

, MCD

McDonald's

$241.80 /

-5.06 (-2.05%)

, SPOT

Spotify

$223.37 /

-13.56 (-5.72%)

, SBUX

Starbucks

$122.49 /

-3.6 (-2.86%)

, MAT

Mattel

$21.55 /

+0.965 (+4.69%)

, BA

Boeing

$231.55 /

+9.35 (+4.21%)

, AMD

AMD

$97.88 /

+6.78 (+7.44%)

, V

Visa

$246.93 /

-3.99 (-1.59%)

, PHG

Philips

$45.49 /

-0.01 (-0.02%)

Get caught up quickly on…

ShowHide Related Items >><<
V Visa
$246.93 /

-3.99 (-1.59%)

TWTR Twitter
$69.94 /

+1.62 (+2.37%)

TLRY Tilray
$16.00 /

+3.27 (+25.69%)

TEVA Teva
$9.99 /

+1.075 (+12.06%)

TDOC Teladoc
$152.12 /

+1.3 (+0.86%)

SPX S&P 500
/

+

SPOT Spotify
$223.37 /

-13.56 (-5.72%)

SBUX Starbucks
$122.49 /

-3.6 (-2.86%)

PHG Philips
$45.49 /

-0.01 (-0.02%)

PFE Pfizer
$43.45 /

+1.39 (+3.30%)

MSFT Microsoft
$286.12 /

-0.77 (-0.27%)

MGM MGM Resorts
$38.40 /

+0.37 (+0.97%)

MCD McDonald's
$241.80 /

-5.06 (-2.05%)

MAT Mattel
$21.55 /

+0.965 (+4.69%)

ISBC Investors Bancorp
$14.43 /

+1.42 (+10.91%)

HRC Hill-Rom
$132.69 /

+8.92 (+7.21%)

HMLP Hoegh LNG Partners
$6.30 /

-11.485 (-64.60%)

GOOG Alphabet
$2,727.64 /

-4.57 (-0.17%)

FLDM Fluidigm
$7.10 /

+0.74 (+11.64%)

CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

CFG Citizens Financial
$43.30 /

-1.025 (-2.31%)

CAKE Cheesecake Factory
$47.76 /

-7.32 (-13.29%)

BAX Baxter
$82.00 /

-0.13 (-0.16%)

BA Boeing
$231.55 /

+9.35 (+4.21%)

ASXC Asensus Surgical
$2.37 /

+0.22 (+10.23%)

AMD AMD
$97.88 /

+6.78 (+7.44%)

AAPL Apple
$144.98 /

-1.8 (-1.23%)

AAPL Apple
$144.98 /

-1.8 (-1.23%)

07/29/21 Craig-Hallum
Cirrus Logic upgraded to Buy at Craig-Hallum on results beat, Apple strength
07/29/21 KeyBanc
Cirrus Logic price target raised to $105 from $100 at KeyBanc
07/28/21 Loop Capital
Apple price target raised to $165 from $150 at Loop Capital
07/28/21 Wedbush
Apple delivers 'gold medal performance' for June, says Wedbush
GOOG Alphabet
$2,727.64 /

-4.57 (-0.17%)

07/29/21 Wells Fargo
Facebook price target raised to $450 from $415 at Wells Fargo
07/29/21 Morgan Stanley
Facebook price target raised to $400 from $375 at Morgan Stanley
07/28/21 Wedbush
Alphabet price target raised to $3,424 from $3,127 at Wedbush
07/28/21 JPMorgan
Alphabet price target raised to $3,250 from $2,875 at JPMorgan
GOOGL Alphabet Class A
$2,722.81 /

+84.175 (+3.19%)

07/29/21 Argus
Alphabet price target raised to $3,100 from $2,800 at Argus
07/28/21 BMO Capital
Alphabet price target raised to $3,000 from $2,700 at BMO Capital
MSFT Microsoft
$286.12 /

-0.77 (-0.27%)

07/28/21 JPMorgan
Microsoft price target raised to $310 from $300 at JPMorgan
07/28/21
Fly Intel: Top five analyst initiations
07/28/21 BMO Capital
Microsoft price target raised to $325 from $290 at BMO Capital
07/28/21 Wedbush
Wedbush bullish on Microsoft following 'robust' results, guidance
PFE Pfizer
$43.45 /

+1.39 (+3.30%)

07/26/21 Truist
Pfizer assumed with a Buy at Truist
07/26/21 Truist
Pfizer assumed with a Buy at Truist
07/23/21 BMO Capital
Arvinas price target raised to $111 from $101 at BMO Capital
07/23/21 Citi
Arvinas price target raised to $153 from $118 at Citi
SPX S&P 500
/

+

03/15/21 Morgan Stanley
Morgan Stanley equity strategist downgrades small cap stocks
03/12/21
On The Fly: Weekly technical notes for S&P 500
01/07/21 Credit Suisse
Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside
11/09/20 JPMorgan
JPMorgan sees S&P 500 hitting 4,000 by early next year
SPY SPDR S&P 500 ETF Trust
$438.80 /

-0.1901 (-0.04%)

TDOC Teladoc
$152.12 /

+1.3 (+0.86%)

07/28/21
Fly Intel: Top five analyst downgrades
07/28/21 SVB Leerink
Teladoc price target lowered to $218 from $266 at SVB Leerink
07/28/21 BTIG
Teladoc price target lowered to $260 from $300 at BTIG
07/28/21 Craig-Hallum
Teladoc price target lowered to $165 from $202 at Craig-Hallum
MGM MGM Resorts
$38.40 /

+0.37 (+0.97%)

07/28/21
Fly Intel: Top five analyst upgrades
07/28/21 Goldman Sachs
MGM Resorts upgraded to Neutral from Sell at Goldman Sachs
06/24/21
Fly Intel: Top five analyst upgrades
06/24/21 Deutsche Bank
Deutsche upgrades MGM Resorts to Buy on margin upside potential
RMD ResMed
$266.01 /

+1.61 (+0.61%)

07/28/21 Jefferies
ResMed upgraded to Hold at Jefferies following survey on Philips recall
07/28/21 Jefferies
ResMed upgraded to Hold from Underperform at Jefferies
07/27/21 RBC Capital
ResMed price target raised to $238 from $223 at RBC Capital
FLDM Fluidigm
$7.10 /

+0.74 (+11.64%)

05/12/21 Piper Sandler
Fluidigm price target lowered to $7 from $8 at Piper Sandler
02/11/21 Piper Sandler
Fluidigm price target lowered to $8 from $15 at Piper Sandler
12/17/20 BTIG
Illumina upgraded to Buy from Neutral at BTIG
11/09/20 Piper Sandler
Buy companies with COVID-19 tests on today's selloff, says Piper Sandler
CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

07/19/21 Barclays
Credit Suisse price target lowered to CHF 12 from CHF 12.50 at Barclays
07/15/21 Jefferies
Credit Suisse initiated with a Hold at Jefferies
07/13/21 Deutsche Bank
Credit Suisse price target lowered to CHF 11 from CHF 12 at Deutsche Bank
07/12/21 Morgan Stanley
Credit Suisse price target lowered to CHF 10 from CHF 11 at Morgan Stanley
TWTR Twitter
$69.94 /

+1.62 (+2.37%)

07/23/21 Jefferies
Twitter price target raised to $80 from $70 at Jefferies
07/23/21 Truist
Twitter price target raised to $80 from $70 at Truist
07/23/21 Oppenheimer
Twitter price target raised to $85 from $70 at Oppenheimer
BAX Baxter
$82.00 /

-0.13 (-0.16%)

07/29/21 KeyBanc
KeyBanc sees a potential acquisition of Hill-Rom 'favorably' for Baxter
07/28/21 KeyBanc
Baxter offer in $150-$165 range would be 'reasonable' for Hill-Rom, says KeyBanc
05/25/21 Barclays
Barclays starts Medical Devices sector with Positive industry view
05/24/21 Barclays
Baxter initiated with an Equal Weight at Barclays
HRC Hill-Rom
$132.69 /

+8.92 (+7.21%)

05/03/21 Baird
Hill-Rom price target raised to $125 from $115 at Baird
02/08/21 Baird
Hill-Rom price target raised to $115 from $105 at Baird
GIW GigInternational1
$9.82 /

-0.04 (-0.41%)

ASXC Asensus Surgical
$2.37 /

+0.22 (+10.23%)

05/26/21 H.C. Wainwright
Asensus Surgical initiated with a Buy at H.C. Wainwright
TEVA Teva
$9.99 /

+1.075 (+12.06%)

06/22/21 JPMorgan
Opioid settlement would be best case for manufacturers, says JPMorgan
05/04/21 UBS
Teva downgraded to Neutral from Buy at UBS
04/06/21 RBC Capital
Teva transferred with a Sector Perform at RBC Capital
01/26/21 Piper Sandler
Amarin in 'strong position' against Health Net, says Piper Sandler
TLRY Tilray
$16.00 /

+3.27 (+25.69%)

07/28/21 Roth Capital
Tilray positioned for further consolidation, says Roth Capital
06/30/21 MKM Partners
Tilray price target raised to $16 from $8.50 at MKM Partners
06/25/21 Alliance Global Partners
Cannabis selloff brings buying opportunities, says Alliance Global
06/23/21 Alliance Global Partners
Tilray price target lowered to $18 from $32 at Alliance Global Partners
HMLP Hoegh LNG Partners
$6.30 /

-11.485 (-64.60%)

07/28/21 B. Riley
Hoegh LNG Partners downgraded to Neutral from Buy at B. Riley
07/28/21 B. Riley
Hoegh LNG Partners downgraded to Neutral from Buy at B. Riley
07/28/21 Barclays
Hoegh LNG Partners downgraded to Underweight from Overweight at Barclays
CFG Citizens Financial
$43.30 /

-1.025 (-2.31%)

07/29/21 Janney Montgomery Scott
Investors Bancorp downgraded to Neutral from Buy at Janney Montgomery Scott
07/29/21 Keefe Bruyette
Investors Bancorp upgraded to Outperform from Market Perform at Keefe Bruyette
07/16/21 Citi
Citizens Financial assumed with a Neutral at Citi
07/06/21 Keefe Bruyette
Citizens Financial assumed with an Outperform at Keefe Bruyette
ISBC Investors Bancorp
$14.43 /

+1.42 (+10.91%)

05/05/21 Stephens
Investors Bancorp downgraded to Equal Weight on valuation at Stephens
05/05/21 Stephens
Investors Bancorp downgraded to Equal Weight from Overweight at Stephens
CAKE Cheesecake Factory
$47.76 /

-7.32 (-13.29%)

07/12/21
Fly Intel: Top five analyst upgrades
07/12/21 Raymond James
Cheesecake Factory upgraded to Outperform from Market Perform at Raymond James
07/12/21 Raymond James
Cheesecake Factory upgraded to Outperform from Market Perform at Raymond James
06/14/21 Wedbush
Cheesecake Factory added to 'Best Ideas List' at Wedbush
MCD McDonald's
$241.80 /

-5.06 (-2.05%)

07/29/21 Stephens
McDonald's price target raised to $260 from $245 at Stephens
07/29/21 Baird
McDonald's price target raised to $262 from $252 at Baird
07/29/21 Argus
McDonald's price target raised to $275 from $260 at Argus
07/29/21 Deutsche Bank
McDonald's price target raised to $264 from $253 at Deutsche Bank
SPOT Spotify
$223.37 /

-13.56 (-5.72%)

07/29/21 Credit Suisse
Spotify price target lowered to $270 from $315 at Credit Suisse
07/29/21 UBS
Spotify upgraded to Neutral from Sell at UBS
07/29/21 Guggenheim
Spotify upgraded to Buy at Guggenheim following nearly 40% pullback
07/29/21 Guggenheim
Spotify upgraded to Buy from Neutral at Guggenheim
SBUX Starbucks
$122.49 /

-3.6 (-2.86%)

07/28/21 MKM Partners
Starbucks price target raised to $132 from $125 at MKM Partners
07/28/21 BMO Capital
Starbucks price target raised to $140 from $125 at BMO Capital
07/28/21 Barclays
Starbucks price target raised to $145 from $140 at Barclays
07/28/21 Piper Sandler
Starbucks price target raised to $108 from $104 at Piper Sandler
MAT Mattel
$21.55 /

+0.965 (+4.69%)

07/28/21 JPMorgan
Mattel price target raised to $28 from $27 at JPMorgan
07/23/21 BMO Capital
BMO 'increasingly more concerned' about guidance from toy companies
06/17/21 JPMorgan
Mattel's 'fast entry' into NFT testament to evolution, says JPMorgan
04/26/21 BMO Capital
Mattel price target raised to $30 from $26 at BMO Capital
BA Boeing
$231.55 /

+9.35 (+4.21%)

07/29/21 Susquehanna
Boeing estimates raised following earnings beat at Susquehanna
07/14/21 Morgan Stanley
Boeing's 787 'minor headache' doesn't change thesis, says Morgan Stanley
07/13/21
Fly Intel: Top five analyst upgrades
07/13/21 Wolfe Research
Boeing upgraded to Peer Perform at Wolfe Research after United's big order
AMD AMD
$97.88 /

+6.78 (+7.44%)

07/29/21 BMO Capital
Xilinx price target raised to $140 from $130 at BMO Capital
07/29/21 Argus
AMD price target raised to $120 from $106 at Argus
07/28/21 Jefferies
AMD remains a top pick at Jefferies, sees server share gains to accelerate
07/28/21 Northland
AMD price target raised to $125 from $116 at Northland
V Visa
$246.93 /

-3.99 (-1.59%)

07/28/21 Wedbush
Visa price target raised to $270 from $250 at Wedbush
07/28/21 Compass Point
Visa price target raised to $290 from $265 at Compass Point
07/28/21 Wells Fargo
Visa price target raised to $280 from $265 at Wells Fargo
07/28/21 Susquehanna
Visa price target raised to $290 from $265 at Susquehanna
PHG Philips
$45.49 /

-0.01 (-0.02%)

07/28/21 UBS
Philips price target lowered to EUR 53 from EUR 56 at UBS
07/28/21 Deutsche Bank
Philips price target lowered to EUR 43 from EUR 44 at Deutsche Bank
07/28/21 BofA
Philips downgraded to Neutral from Buy at BofA
V Visa
$246.93 /

-3.99 (-1.59%)

TWTR Twitter
$69.94 /

+1.62 (+2.37%)

TLRY Tilray
$16.00 /

+3.27 (+25.69%)

TEVA Teva
$9.99 /

+1.075 (+12.06%)

TDOC Teladoc
$152.12 /

+1.3 (+0.86%)

SPX S&P 500
/

+

SPOT Spotify
$223.37 /

-13.56 (-5.72%)

SBUX Starbucks
$122.49 /

-3.6 (-2.86%)

RMD ResMed
$266.01 /

+1.61 (+0.61%)

PHG Philips
$45.49 /

-0.01 (-0.02%)

PFE Pfizer
$43.45 /

+1.39 (+3.30%)

MSFT Microsoft
$286.12 /

-0.77 (-0.27%)

MGM MGM Resorts
$38.40 /

+0.37 (+0.97%)

MCD McDonald's
$241.80 /

-5.06 (-2.05%)

MAT Mattel
$21.55 /

+0.965 (+4.69%)

ISBC Investors Bancorp
$14.43 /

+1.42 (+10.91%)

HRC Hill-Rom
$132.69 /

+8.92 (+7.21%)

HMLP Hoegh LNG Partners
$6.30 /

-11.485 (-64.60%)

GOOG Alphabet
$2,727.64 /

-4.57 (-0.17%)

FLDM Fluidigm
$7.10 /

+0.74 (+11.64%)

CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

CFG Citizens Financial
$43.30 /

-1.025 (-2.31%)

CAKE Cheesecake Factory
$47.76 /

-7.32 (-13.29%)

BAX Baxter
$82.00 /

-0.13 (-0.16%)

BA Boeing
$231.55 /

+9.35 (+4.21%)

ASXC Asensus Surgical
$2.37 /

+0.22 (+10.23%)

AMD AMD
$97.88 /

+6.78 (+7.44%)

AAPL Apple
$144.98 /

-1.8 (-1.23%)

  • 11
    Jun
  • 13
    Oct
V Visa
$246.93 /

-3.99 (-1.59%)

TWTR Twitter
$69.94 /

+1.62 (+2.37%)

TLRY Tilray
$16.00 /

+3.27 (+25.69%)

TEVA Teva
$9.99 /

+1.075 (+12.06%)

TDOC Teladoc
$152.12 /

+1.3 (+0.86%)

SPX S&P 500
/

+

SPOT Spotify
$223.37 /

-13.56 (-5.72%)

SBUX Starbucks
$122.49 /

-3.6 (-2.86%)

PFE Pfizer
$43.45 /

+1.39 (+3.30%)

MSFT Microsoft
$286.12 /

-0.77 (-0.27%)

MGM MGM Resorts
$38.40 /

+0.37 (+0.97%)

MCD McDonald's
$241.80 /

-5.06 (-2.05%)

MAT Mattel
$21.55 /

+0.965 (+4.69%)

GOOG Alphabet
$2,727.64 /

-4.57 (-0.17%)

GIW GigInternational1
$9.82 /

-0.04 (-0.41%)

FLDM Fluidigm
$7.10 /

+0.74 (+11.64%)

CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

CFG Citizens Financial
$43.30 /

-1.025 (-2.31%)

BAX Baxter
$82.00 /

-0.13 (-0.16%)

BA Boeing
$231.55 /

+9.35 (+4.21%)

AMD AMD
$97.88 /

+6.78 (+7.44%)

AAPL Apple
$144.98 /

-1.8 (-1.23%)

V Visa
$246.93 /

-3.99 (-1.59%)

TLRY Tilray
$16.00 /

+3.27 (+25.69%)

TEVA Teva
$9.99 /

+1.075 (+12.06%)

SPOT Spotify
$223.37 /

-13.56 (-5.72%)

PHG Philips
$45.49 /

-0.01 (-0.02%)

PFE Pfizer
$43.45 /

+1.39 (+3.30%)

MSFT Microsoft
$286.12 /

-0.77 (-0.27%)

MCD McDonald's
$241.80 /

-5.06 (-2.05%)

MAT Mattel
$21.55 /

+0.965 (+4.69%)

GOOG Alphabet
$2,727.64 /

-4.57 (-0.17%)

FLDM Fluidigm
$7.10 /

+0.74 (+11.64%)

CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

CFG Citizens Financial
$43.30 /

-1.025 (-2.31%)

CAKE Cheesecake Factory
$47.76 /

-7.32 (-13.29%)

BA Boeing
$231.55 /

+9.35 (+4.21%)

ASXC Asensus Surgical
$2.37 /

+0.22 (+10.23%)

AMD AMD
$97.88 /

+6.78 (+7.44%)

AAPL Apple
$144.98 /

-1.8 (-1.23%)

V Visa
$246.93 /

-3.99 (-1.59%)

TWTR Twitter
$69.94 /

+1.62 (+2.37%)

TLRY Tilray
$16.00 /

+3.27 (+25.69%)

TEVA Teva
$9.99 /

+1.075 (+12.06%)

TDOC Teladoc
$152.12 /

+1.3 (+0.86%)

SPX S&P 500
/

+

SPOT Spotify
$223.37 /

-13.56 (-5.72%)

SBUX Starbucks
$122.49 /

-3.6 (-2.86%)

RMD ResMed
$266.01 /

+1.61 (+0.61%)

PFE Pfizer
$43.45 /

+1.39 (+3.30%)

MSFT Microsoft
$286.12 /

-0.77 (-0.27%)

MGM MGM Resorts
$38.40 /

+0.37 (+0.97%)

MCD McDonald's
$241.80 /

-5.06 (-2.05%)

HMLP Hoegh LNG Partners
$6.30 /

-11.485 (-64.60%)

GOOGL Alphabet Class A
$2,722.81 /

+84.175 (+3.19%)

GOOG Alphabet
$2,727.64 /

-4.57 (-0.17%)

CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

CFG Citizens Financial
$43.30 /

-1.025 (-2.31%)

BA Boeing
$231.55 /

+9.35 (+4.21%)

ASXC Asensus Surgical
$2.37 /

+0.22 (+10.23%)

AMD AMD
$97.88 /

+6.78 (+7.44%)

AAPL Apple
$144.98 /

-1.8 (-1.23%)

SPY SPDR S&P 500 ETF Trust
$438.80 /

-0.1901 (-0.04%)

SPX S&P 500
/

+

On The Fly
Wall Street in Fives - Must Read Lists at Midday » 12:36
07/28/21
07/28
12:36
07/28/21
12:36
AAPL

Apple

$145.12 /

-1.66 (-1.13%)

, GOOG

Alphabet

$2,755.39 /

+23.18 (+0.85%)

, GOOGL

Alphabet Class A

$2,738.04 /

+99.405 (+3.77%)

, MSFT

Microsoft

$287.24 /

+0.35 (+0.12%)

, PFE

Pfizer

$43.42 /

+1.36 (+3.23%)

, MCD

McDonald's

$240.10 /

-6.76 (-2.74%)

, FLDM

Fluidigm

$6.95 /

+0.59 (+9.28%)

, CS

Credit Suisse

$10.20 /

-0.02 (-0.20%)

, TWTR

Twitter

$70.95 /

+2.63 (+3.85%)

, SPX

S&P 500

/

+

, SPY

SPDR S&P 500 ETF Trust

$439.02 /

+0.03 (+0.01%)

, BNTX

BioNTech

$296.64 /

+12.555 (+4.42%)

, JNJ

Johnson & Johnson

$172.83 /

+0.185 (+0.11%)

, MRNA

Moderna

$338.15 /

+9.765 (+2.97%)

, ASXC

Asensus Surgical

$2.38 /

+0.225 (+10.47%)

, TLRY

Tilray

$16.01 /

+3.28 (+25.77%)

, TEVA

Teva

$10.05 /

+1.13 (+12.68%)

, HMLP

Hoegh LNG Partners

$6.78 /

-11 (-61.87%)

, CFG

Citizens Financial

$42.79 /

-1.535 (-3.46%)

, ISBC

Investors Bancorp

$14.11 /

+1.1 (+8.46%)

, CAKE

Cheesecake Factory

$48.93 /

-6.15 (-11.17%)

, SPOT

Spotify

$220.03 /

-16.9 (-7.13%)

, CSGP

CoStar Group

$84.24 /

-4.68 (-5.26%)

, SBUX

Starbucks

$122.55 /

-3.54 (-2.81%)

, MAT

Mattel

$21.71 /

+1.13 (+5.49%)

, BA

Boeing

$233.20 /

+11 (+4.95%)

, AMD

AMD

$96.91 /

+5.81 (+6.38%)

, V

Visa

$247.47 /

-3.45 (-1.37%)

, TDOC

Teladoc

$150.10 /

-0.72 (-0.48%)

, MGM

MGM Resorts

$38.44 /

+0.41 (+1.08%)

, RMD

ResMed

$265.02 /

+0.62 (+0.23%)

, PHG

Philips

$45.52 /

+0.02 (+0.04%)

, HRC

Hill-Rom

$135.30 /

+11.53 (+9.32%)

, BAX

Baxter

$81.70 /

-0.43 (-0.52%)

Get caught up quickly on…

ShowHide Related Items >><<
V Visa
$247.47 /

-3.45 (-1.37%)

TWTR Twitter
$70.95 /

+2.63 (+3.85%)

TLRY Tilray
$16.01 /

+3.28 (+25.77%)

TEVA Teva
$10.05 /

+1.13 (+12.68%)

TDOC Teladoc
$150.10 /

-0.72 (-0.48%)

SPX S&P 500
/

+

SPOT Spotify
$220.03 /

-16.9 (-7.13%)

SBUX Starbucks
$122.55 /

-3.54 (-2.81%)

PHG Philips
$45.52 /

+0.02 (+0.04%)

PFE Pfizer
$43.42 /

+1.36 (+3.23%)

MSFT Microsoft
$287.24 /

+0.35 (+0.12%)

MRNA Moderna
$338.15 /

+9.765 (+2.97%)

MGM MGM Resorts
$38.44 /

+0.41 (+1.08%)

MCD McDonald's
$240.10 /

-6.76 (-2.74%)

MAT Mattel
$21.71 /

+1.13 (+5.49%)

JNJ Johnson & Johnson
$172.83 /

+0.185 (+0.11%)

ISBC Investors Bancorp
$14.11 /

+1.1 (+8.46%)

HRC Hill-Rom
$135.30 /

+11.53 (+9.32%)

HMLP Hoegh LNG Partners
$6.78 /

-11 (-61.87%)

GOOG Alphabet
$2,755.39 /

+23.18 (+0.85%)

FLDM Fluidigm
$6.95 /

+0.59 (+9.28%)

CSGP CoStar Group
$84.24 /

-4.68 (-5.26%)

CS Credit Suisse
$10.20 /

-0.02 (-0.20%)

CFG Citizens Financial
$42.79 /

-1.535 (-3.46%)

CAKE Cheesecake Factory
$48.93 /

-6.15 (-11.17%)

BNTX BioNTech
$296.64 /

+12.555 (+4.42%)

BAX Baxter
$81.70 /

-0.43 (-0.52%)

BA Boeing
$233.20 /

+11 (+4.95%)

ASXC Asensus Surgical
$2.38 /

+0.225 (+10.47%)

AMD AMD
$96.91 /

+5.81 (+6.38%)

AAPL Apple
$145.12 /

-1.66 (-1.13%)

AAPL Apple
$145.12 /

-1.66 (-1.13%)

07/28/21 Loop Capital
Apple price target raised to $165 from $150 at Loop Capital
07/28/21 Wedbush
Apple delivers 'gold medal performance' for June, says Wedbush
07/28/21 UBS
Apple price target raised to $175 from $166 at UBS
07/28/21 JPMorgan
Apple long-term drivers unaffected by 'temporal headwinds,' says JPMorgan
GOOG Alphabet
$2,755.39 /

+23.18 (+0.85%)

07/28/21 Wedbush
Alphabet price target raised to $3,424 from $3,127 at Wedbush
07/28/21 JPMorgan
Alphabet price target raised to $3,250 from $2,875 at JPMorgan
07/28/21 KeyBanc
Alphabet price target raised to $3,071 from $2,681 at KeyBanc
07/28/21 Credit Suisse
Alphabet Class A price target raised to $3,400 from $3,350 at Credit Suisse
GOOGL Alphabet Class A
$2,738.04 /

+99.405 (+3.77%)

07/28/21 BMO Capital
Alphabet price target raised to $3,000 from $2,700 at BMO Capital
07/28/21 MKM Partners
Alphabet price target raised to $3,150 from $2,500 at MKM Partners
MSFT Microsoft
$287.24 /

+0.35 (+0.12%)

07/28/21
Fly Intel: Top five analyst initiations
07/28/21 BMO Capital
Microsoft price target raised to $325 from $290 at BMO Capital
07/28/21 Wedbush
Wedbush bullish on Microsoft following 'robust' results, guidance
07/28/21 Credit Suisse
Microsoft price target raised to $320 from $300 at Credit Suisse
PFE Pfizer
$43.42 /

+1.36 (+3.23%)

07/26/21 Truist
Pfizer assumed with a Buy at Truist
07/26/21 Truist
Pfizer assumed with a Buy at Truist
07/23/21 BMO Capital
Arvinas price target raised to $111 from $101 at BMO Capital
07/23/21 Citi
Arvinas price target raised to $153 from $118 at Citi
MCD McDonald's
$240.10 /

-6.76 (-2.74%)

07/26/21 Guggenheim
McDonald's initiated with a Buy at Guggenheim
07/20/21 UBS
McDonald's checks suggest continued U.S. comp momentum, says UBS
07/16/21 Wedbush
McDonald's price target raised to $265 from $260 at Wedbush
06/25/21 Tigress Financial
McDonald's shares going to $271 in 12 months, says Tigress Financial
FLDM Fluidigm
$6.95 /

+0.59 (+9.28%)

05/12/21 Piper Sandler
Fluidigm price target lowered to $7 from $8 at Piper Sandler
02/11/21 Piper Sandler
Fluidigm price target lowered to $8 from $15 at Piper Sandler
12/17/20 BTIG
Illumina upgraded to Buy from Neutral at BTIG
11/09/20 Piper Sandler
Buy companies with COVID-19 tests on today's selloff, says Piper Sandler
CS Credit Suisse
$10.20 /

-0.02 (-0.20%)

07/19/21 Barclays
Credit Suisse price target lowered to CHF 12 from CHF 12.50 at Barclays
07/15/21 Jefferies
Credit Suisse initiated with a Hold at Jefferies
07/13/21 Deutsche Bank
Credit Suisse price target lowered to CHF 11 from CHF 12 at Deutsche Bank
07/12/21 Morgan Stanley
Credit Suisse price target lowered to CHF 10 from CHF 11 at Morgan Stanley
TWTR Twitter
$70.95 /

+2.63 (+3.85%)

07/23/21 Jefferies
Twitter price target raised to $80 from $70 at Jefferies
07/23/21 Truist
Twitter price target raised to $80 from $70 at Truist
07/23/21 Oppenheimer
Twitter price target raised to $85 from $70 at Oppenheimer
07/23/21 Canaccord
Twitter price target raised to $78 from $68 at Canaccord
SPX S&P 500
/

+

03/15/21 Morgan Stanley
Morgan Stanley equity strategist downgrades small cap stocks
03/12/21
On The Fly: Weekly technical notes for S&P 500
01/07/21 Credit Suisse
Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside
11/09/20 JPMorgan
JPMorgan sees S&P 500 hitting 4,000 by early next year
SPY SPDR S&P 500 ETF Trust
$439.02 /

+0.03 (+0.01%)

BNTX BioNTech
$296.64 /

+12.555 (+4.42%)

07/19/21 Wolfe Research
BioNTech assumed with an Outperform at Wolfe Research
06/16/21
Fly Intel: Top five analyst downgrades
06/16/21 Redburn
BioNTech downgraded to Sell from Neutral at Redburn
05/18/21
Fly Intel: Top five analyst initiations
JNJ Johnson & Johnson
$172.83 /

+0.185 (+0.11%)

07/08/21 Stifel
Vor Biopharma, Janssen collaboration benefits both parties, says Stifel
07/02/21 Cantor Fitzgerald
J&J vaccine shows 'strong' activist against Delta, says Cantor Fitzgerald
06/28/21 Cantor Fitzgerald
J&J opioid settlement removes share overhang, says Cantor Fitzgerald
06/22/21 JPMorgan
Opioid settlement would be best case for manufacturers, says JPMorgan
MRNA Moderna
$338.15 /

+9.765 (+2.97%)

07/15/21 Jefferies
Moderna price target raised to $250 from $170 at Jefferies
07/07/21 Piper Sandler
Moderna could 'revolutionize' flu vaccine market, says Piper Sandler
06/29/21 Wells Fargo
Moderna vaccine demonstrates activity against key variants, says Wells Fargo
06/29/21 Goldman Sachs
Goldman continues to anticipate clinical need for booster vaccines
ASXC Asensus Surgical
$2.38 /

+0.225 (+10.47%)

05/26/21 H.C. Wainwright
Asensus Surgical initiated with a Buy at H.C. Wainwright
TLRY Tilray
$16.01 /

+3.28 (+25.77%)

06/30/21 MKM Partners
Tilray price target raised to $16 from $8.50 at MKM Partners
06/25/21 Alliance Global Partners
Cannabis selloff brings buying opportunities, says Alliance Global
06/23/21 Alliance Global Partners
Tilray price target lowered to $18 from $32 at Alliance Global Partners
06/11/21
Fly Intel: Top five analyst downgrades
TEVA Teva
$10.05 /

+1.13 (+12.68%)

05/04/21 UBS
Teva downgraded to Neutral from Buy at UBS
04/06/21 RBC Capital
Teva transferred with a Sector Perform at RBC Capital
01/26/21 Piper Sandler
Amarin in 'strong position' against Health Net, says Piper Sandler
HMLP Hoegh LNG Partners
$6.78 /

-11 (-61.87%)

07/28/21
Fly Intel: Top five analyst downgrades
07/28/21 B. Riley
Hoegh LNG Partners downgraded to Neutral from Buy at B. Riley
07/28/21 B. Riley
Hoegh LNG Partners downgraded to Neutral from Buy at B. Riley
07/28/21 Barclays
Hoegh LNG Partners downgraded to Underweight from Overweight at Barclays
CFG Citizens Financial
$42.79 /

-1.535 (-3.46%)

07/16/21 Citi
Citizens Financial assumed with a Neutral at Citi
07/06/21 Keefe Bruyette
Citizens Financial assumed with an Outperform at Keefe Bruyette
05/18/21 Compass Point
Citizens Financial price target raised to $55 from $51 at Compass Point
05/03/21 JPMorgan
Citizens Financial price target raised to $50 from $48 at JPMorgan
ISBC Investors Bancorp
$14.11 /

+1.1 (+8.46%)

05/05/21 Stephens
Investors Bancorp downgraded to Equal Weight on valuation at Stephens
05/05/21 Stephens
Investors Bancorp downgraded to Equal Weight from Overweight at Stephens
04/26/21 Keefe Bruyette
Investors Bancorp initiated with a Market Perform at Keefe Bruyette
04/08/21 RBC Capital
Investors Bancorp price target raised to $18 from $16 at RBC Capital
CAKE Cheesecake Factory
$48.93 /

-6.15 (-11.17%)

07/12/21
Fly Intel: Top five analyst upgrades
07/12/21 Raymond James
Cheesecake Factory upgraded to Outperform from Market Perform at Raymond James
07/12/21 Raymond James
Cheesecake Factory upgraded to Outperform from Market Perform at Raymond James
06/14/21 Wedbush
Cheesecake Factory added to 'Best Ideas List' at Wedbush
SPOT Spotify
$220.03 /

-16.9 (-7.13%)

07/26/21 Redburn
Redburn downgrades 'cornered' Spotify to Sell, sees 30% downside
07/26/21 Redburn
Spotify downgraded to Sell from Neutral at Redburn
06/08/21 Citi
Spotify price target lowered to $275 from $310 at Citi
06/02/21 Evercore ISI
Survey results positive for Spotify, says Evercore ISI
CSGP CoStar Group
$84.24 /

-4.68 (-5.26%)

07/28/21 Truist
CoStar Group price target lowered to $98 from $107 at Truist
07/21/21 Stephens
CoStar Group resumed with an Overweight at Stephens
04/28/21 JMP Securities
CoStar Group price target raised to $1,025 from $950 at JMP Securities
03/15/21 Goldman Sachs
CoStar Group reinstated with a Buy at Goldman Sachs
SBUX Starbucks
$122.55 /

-3.54 (-2.81%)

07/28/21 MKM Partners
Starbucks price target raised to $132 from $125 at MKM Partners
07/28/21 BMO Capital
Starbucks price target raised to $140 from $125 at BMO Capital
07/28/21 Barclays
Starbucks price target raised to $145 from $140 at Barclays
07/28/21 Piper Sandler
Starbucks price target raised to $108 from $104 at Piper Sandler
MAT Mattel
$21.71 /

+1.13 (+5.49%)

07/28/21 JPMorgan
Mattel price target raised to $28 from $27 at JPMorgan
07/23/21 BMO Capital
BMO 'increasingly more concerned' about guidance from toy companies
06/17/21 JPMorgan
Mattel's 'fast entry' into NFT testament to evolution, says JPMorgan
04/26/21 BMO Capital
Mattel price target raised to $30 from $26 at BMO Capital
BA Boeing
$233.20 /

+11 (+4.95%)

07/14/21 Morgan Stanley
Boeing's 787 'minor headache' doesn't change thesis, says Morgan Stanley
07/13/21
Fly Intel: Top five analyst upgrades
07/13/21 Wolfe Research
Boeing upgraded to Peer Perform at Wolfe Research after United's big order
07/13/21 Wolfe Research
Boeing upgraded to Peer Perform from Underperform at Wolfe Research
AMD AMD
$96.91 /

+5.81 (+6.38%)

07/28/21 Jefferies
AMD remains a top pick at Jefferies, sees server share gains to accelerate
07/28/21 Northland
AMD price target raised to $125 from $116 at Northland
07/28/21 Susquehanna
AMD price target raised to $130 from $125 at Susquehanna
07/28/21 Rosenblatt
AMD price target raised to $150 from $135 at Rosenblatt
V Visa
$247.47 /

-3.45 (-1.37%)

07/28/21 Wedbush
Visa price target raised to $270 from $250 at Wedbush
07/28/21 Compass Point
Visa price target raised to $290 from $265 at Compass Point
07/28/21 Wells Fargo
Visa price target raised to $280 from $265 at Wells Fargo
07/28/21 Susquehanna
Visa price target raised to $290 from $265 at Susquehanna
TDOC Teladoc
$150.10 /

-0.72 (-0.48%)

07/28/21 SVB Leerink
Teladoc price target lowered to $218 from $266 at SVB Leerink
07/28/21 BTIG
Teladoc price target lowered to $260 from $300 at BTIG
07/28/21 Craig-Hallum
Teladoc price target lowered to $165 from $202 at Craig-Hallum
MGM MGM Resorts
$38.44 /

+0.41 (+1.08%)

07/28/21
Fly Intel: Top five analyst upgrades
07/28/21 Goldman Sachs
MGM Resorts upgraded to Neutral from Sell at Goldman Sachs
06/24/21
Fly Intel: Top five analyst upgrades
06/24/21 Deutsche Bank
Deutsche upgrades MGM Resorts to Buy on margin upside potential
RMD ResMed
$265.02 /

+0.62 (+0.23%)

07/28/21 Jefferies
ResMed upgraded to Hold at Jefferies following survey on Philips recall
07/28/21 Jefferies
ResMed upgraded to Hold from Underperform at Jefferies
07/27/21 RBC Capital
ResMed price target raised to $238 from $223 at RBC Capital
PHG Philips
$45.52 /

+0.02 (+0.04%)

07/28/21 BofA
Philips downgraded to Neutral from Buy at BofA
07/28/21 Oddo BHF
Philips upgraded to Outperform from Neutral at Oddo BHF
07/14/21 Baird
AdaptHealth upgraded to Outperform on increasing investor confidence at Baird
HRC Hill-Rom
$135.30 /

+11.53 (+9.32%)

05/03/21 Baird
Hill-Rom price target raised to $125 from $115 at Baird
02/08/21 Baird
Hill-Rom price target raised to $115 from $105 at Baird
01/25/21 Morgan Stanley
iRhythm price target raised to $288 from $227 at Morgan Stanley
11/04/20
Fly Intel: Top five analyst downgrades
BAX Baxter
$81.70 /

-0.43 (-0.52%)

05/25/21 Barclays
Barclays starts Medical Devices sector with Positive industry view
05/24/21 Barclays
Baxter initiated with an Equal Weight at Barclays
04/30/21 Citi
Baxter price target raised to $98 from $94 at Citi
04/29/21 Piper Sandler
Baxter price target raised to $85 from $80 at Piper Sandler
V Visa
$247.47 /

-3.45 (-1.37%)

TWTR Twitter
$70.95 /

+2.63 (+3.85%)

TLRY Tilray
$16.01 /

+3.28 (+25.77%)

TEVA Teva
$10.05 /

+1.13 (+12.68%)

TDOC Teladoc
$150.10 /

-0.72 (-0.48%)

SPX S&P 500
/

+

SPOT Spotify
$220.03 /

-16.9 (-7.13%)

SBUX Starbucks
$122.55 /

-3.54 (-2.81%)

RMD ResMed
$265.02 /

+0.62 (+0.23%)

PHG Philips
$45.52 /

+0.02 (+0.04%)

PFE Pfizer
$43.42 /

+1.36 (+3.23%)

MSFT Microsoft
$287.24 /

+0.35 (+0.12%)

MRNA Moderna
$338.15 /

+9.765 (+2.97%)

MGM MGM Resorts
$38.44 /

+0.41 (+1.08%)

MCD McDonald's
$240.10 /

-6.76 (-2.74%)

MAT Mattel
$21.71 /

+1.13 (+5.49%)

JNJ Johnson & Johnson
$172.83 /

+0.185 (+0.11%)

ISBC Investors Bancorp
$14.11 /

+1.1 (+8.46%)

HRC Hill-Rom
$135.30 /

+11.53 (+9.32%)

HMLP Hoegh LNG Partners
$6.78 /

-11 (-61.87%)

GOOG Alphabet
$2,755.39 /

+23.18 (+0.85%)

FLDM Fluidigm
$6.95 /

+0.59 (+9.28%)

CSGP CoStar Group
$84.24 /

-4.68 (-5.26%)

CS Credit Suisse
$10.20 /

-0.02 (-0.20%)

CFG Citizens Financial
$42.79 /

-1.535 (-3.46%)

CAKE Cheesecake Factory
$48.93 /

-6.15 (-11.17%)

BNTX BioNTech
$296.64 /

+12.555 (+4.42%)

BAX Baxter
$81.70 /

-0.43 (-0.52%)

BA Boeing
$233.20 /

+11 (+4.95%)

ASXC Asensus Surgical
$2.38 /

+0.225 (+10.47%)

AMD AMD
$96.91 /

+5.81 (+6.38%)

AAPL Apple
$145.12 /

-1.66 (-1.13%)

  • 11
    Jun
  • 13
    Oct
V Visa
$247.47 /

-3.45 (-1.37%)

TWTR Twitter
$70.95 /

+2.63 (+3.85%)

TLRY Tilray
$16.01 /

+3.28 (+25.77%)

TEVA Teva
$10.05 /

+1.13 (+12.68%)

TDOC Teladoc
$150.10 /

-0.72 (-0.48%)

SPX S&P 500
/

+

SPOT Spotify
$220.03 /

-16.9 (-7.13%)

SBUX Starbucks
$122.55 /

-3.54 (-2.81%)

PFE Pfizer
$43.42 /

+1.36 (+3.23%)

MSFT Microsoft
$287.24 /

+0.35 (+0.12%)

MRNA Moderna
$338.15 /

+9.765 (+2.97%)

MGM MGM Resorts
$38.44 /

+0.41 (+1.08%)

MCD McDonald's
$240.10 /

-6.76 (-2.74%)

MAT Mattel
$21.71 /

+1.13 (+5.49%)

HRC Hill-Rom
$135.30 /

+11.53 (+9.32%)

GOOG Alphabet
$2,755.39 /

+23.18 (+0.85%)

FLDM Fluidigm
$6.95 /

+0.59 (+9.28%)

CSGP CoStar Group
$84.24 /

-4.68 (-5.26%)

CS Credit Suisse
$10.20 /

-0.02 (-0.20%)

CFG Citizens Financial
$42.79 /

-1.535 (-3.46%)

BNTX BioNTech
$296.64 /

+12.555 (+4.42%)

BAX Baxter
$81.70 /

-0.43 (-0.52%)

BA Boeing
$233.20 /

+11 (+4.95%)

AMD AMD
$96.91 /

+5.81 (+6.38%)

AAPL Apple
$145.12 /

-1.66 (-1.13%)

V Visa
$247.47 /

-3.45 (-1.37%)

TWTR Twitter
$70.95 /

+2.63 (+3.85%)

TLRY Tilray
$16.01 /

+3.28 (+25.77%)

TEVA Teva
$10.05 /

+1.13 (+12.68%)

TDOC Teladoc
$150.10 /

-0.72 (-0.48%)

SPOT Spotify
$220.03 /

-16.9 (-7.13%)

PHG Philips
$45.52 /

+0.02 (+0.04%)

PFE Pfizer
$43.42 /

+1.36 (+3.23%)

MSFT Microsoft
$287.24 /

+0.35 (+0.12%)

MRNA Moderna
$338.15 /

+9.765 (+2.97%)

MGM MGM Resorts
$38.44 /

+0.41 (+1.08%)

MCD McDonald's
$240.10 /

-6.76 (-2.74%)

MAT Mattel
$21.71 /

+1.13 (+5.49%)

JNJ Johnson & Johnson
$172.83 /

+0.185 (+0.11%)

GOOG Alphabet
$2,755.39 /

+23.18 (+0.85%)

FLDM Fluidigm
$6.95 /

+0.59 (+9.28%)

CSGP CoStar Group
$84.24 /

-4.68 (-5.26%)

CS Credit Suisse
$10.20 /

-0.02 (-0.20%)

CFG Citizens Financial
$42.79 /

-1.535 (-3.46%)

CAKE Cheesecake Factory
$48.93 /

-6.15 (-11.17%)

BNTX BioNTech
$296.64 /

+12.555 (+4.42%)

BA Boeing
$233.20 /

+11 (+4.95%)

ASXC Asensus Surgical
$2.38 /

+0.225 (+10.47%)

AMD AMD
$96.91 /

+5.81 (+6.38%)

AAPL Apple
$145.12 /

-1.66 (-1.13%)

V Visa
$247.47 /

-3.45 (-1.37%)

TWTR Twitter
$70.95 /

+2.63 (+3.85%)

TLRY Tilray
$16.01 /

+3.28 (+25.77%)

TEVA Teva
$10.05 /

+1.13 (+12.68%)

TDOC Teladoc
$150.10 /

-0.72 (-0.48%)

SPX S&P 500
/

+

SPOT Spotify
$220.03 /

-16.9 (-7.13%)

SBUX Starbucks
$122.55 /

-3.54 (-2.81%)

RMD ResMed
$265.02 /

+0.62 (+0.23%)

PFE Pfizer
$43.42 /

+1.36 (+3.23%)

MSFT Microsoft
$287.24 /

+0.35 (+0.12%)

MRNA Moderna
$338.15 /

+9.765 (+2.97%)

MGM MGM Resorts
$38.44 /

+0.41 (+1.08%)

MCD McDonald's
$240.10 /

-6.76 (-2.74%)

JNJ Johnson & Johnson
$172.83 /

+0.185 (+0.11%)

HMLP Hoegh LNG Partners
$6.78 /

-11 (-61.87%)

GOOGL Alphabet Class A
$2,738.04 /

+99.405 (+3.77%)

GOOG Alphabet
$2,755.39 /

+23.18 (+0.85%)

CS Credit Suisse
$10.20 /

-0.02 (-0.20%)

CFG Citizens Financial
$42.79 /

-1.535 (-3.46%)

BNTX BioNTech
$296.64 /

+12.555 (+4.42%)

BA Boeing
$233.20 /

+11 (+4.95%)

ASXC Asensus Surgical
$2.38 /

+0.225 (+10.47%)

AMD AMD
$96.91 /

+5.81 (+6.38%)

AAPL Apple
$145.12 /

-1.66 (-1.13%)

SPY SPDR S&P 500 ETF Trust
$439.02 /

+0.03 (+0.01%)

SPX S&P 500
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.